Humanigen Inc HGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:43 PM EDT
0.3737quote price arrow down-0.0095 (-2.4791%)
Volume
3,812,228
52 week range
0.35 - 18.22
Loading...
  • Open0.3728
  • Day High0.3789
  • Day Low0.3682
  • Prev Close0.3832
  • 52 Week High18.22
  • 52 Week High Date08/26/21
  • 52 Week Low0.35
  • 52 Week Low Date08/09/22

Key Stats

  • Market Cap38.74M
  • Shares Out103.66M
  • 10 Day Average Volume10.76M
  • Dividend-
  • Dividend Yield-
  • Beta-1.27
  • YTD % Change-89.96

KEY STATS

  • Open0.3728
  • Day High0.3789
  • Day Low0.3682
  • Prev Close0.3832
  • 52 Week High18.22
  • 52 Week High Date08/26/21
  • 52 Week Low0.35
  • 52 Week Low Date08/09/22
  • Market Cap38.74M
  • Shares Out103.66M
  • 10 Day Average Volume10.76M
  • Dividend-
  • Dividend Yield-
  • Beta-1.27
  • YTD % Change-89.96

RATIOS/PROFITABILITY

  • EPS (TTM)-2.40
  • P/E (TTM)-0.16
  • Fwd P/E (NTM)-0.45
  • EBITDA (TTM)-148.204M
  • ROE (TTM)-2,165.43%
  • Revenue (TTM)4.14M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,659.98%
  • Debt To Equity (MRQ)-50.68%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Humanigen Inc

There is no recent news for this security.

Profile

MORE
Humanigen, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing its portfolio of Humaneered anti-inflammatory immunology and immuno-oncology monoclonal antibodies. Its Humaneered technology platform offers a method for converting existing antibodies into engineered human antibodies designed for therapeutic use, primarily with acute and chronic conditions. The Company’s lead product candidate, lenzilumab, and its other two product...
Cameron Durrant M.D.
Chairman of the Board, Chief Executive Officer
Timothy Morris CPA
Chief Financial Officer, Chief Operating Officer
Address
830 MORRIS TURNPIKE, 4TH FLOOR
Short Hills, NJ
07078
United States

Top Peers

SYMBOLLASTCHG%CHG
ABEO
Abeona Therapeutics Inc
4.71+0.07+1.40%
OPGN
OpGen Inc
0.5624-0.025-4.256%
JAGX
Jaguar Health Inc
0.2808-0.0177-5.9296%
BCDA
BioCardia Inc
1.68UNCHUNCH
CYTH
Cyclo Therapeutics Inc
2.43-0.05-2.02%